A Mixed Methods Study of Anticipated and Experienced Stigma in Health Care Settings Among Women Living with HIV in the United States.
Adaptation, Psychological
Aged
Anti-Retroviral Agents
/ therapeutic use
Depression
Fear
Female
HIV Infections
/ drug therapy
Humans
Interviews as Topic
Medication Adherence
/ ethnology
Middle Aged
Patient Compliance
/ ethnology
Qualitative Research
Social Stigma
Surveys and Questionnaires
United States
/ epidemiology
Young Adult
HIV/AIDS
adherence
antiretroviral therapy
mental health
mixed methods
stigma
Journal
AIDS patient care and STDs
ISSN: 1557-7449
Titre abrégé: AIDS Patient Care STDS
Pays: United States
ID NLM: 9607225
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
entrez:
2
4
2019
pubmed:
2
4
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Among places where people living with HIV experience and anticipate HIV-related stigma, stigma in health care settings may be particularly harmful. Utilizing an exploratory sequential mixed methods approach, we conducted interviews (n = 76) and questionnaires (N = 460) with older adult women living with HIV enrolled in the Women's Interagency HIV Study in Birmingham, AL; Jackson, MS; Atlanta, GA; and San Francisco, CA. Interviews addressed facilitators and barriers to HIV treatment adherence, including HIV-related stigma. Qualitative data were coded using thematic analysis. Questionnaires assessed self-reported antiretroviral therapy (ART) adherence and experienced and anticipated HIV-related stigma from various sources (i.e., health care personnel, family, partner, and community). Covariate-adjusted logistic regression analyses examined total and mediated effects of stigma on ART adherence. Interviewees described fears and experiences of stigma in health care settings; including privacy violations, disrespect for patient autonomy, and reproductive coercion; and how these influenced their adherence to HIV treatment recommendations. Experienced and anticipated HIV-related stigma in health care settings were associated with suboptimal (or <95%) ART adherence in separate models controlling for experienced or anticipated stigma, respectively, from other sources. When entered together, only anticipated stigma in health care settings was associated with suboptimal ART adherence, controlling for anticipated and experienced stigma from other sources. The effect of anticipated stigma in health care settings on suboptimal ART adherence may work through the pathways of lower adherence self-efficacy, higher depressive symptoms, and higher coping by substance use. These findings indicate that interventions should promote cultures of acceptance within health care settings and resilience-based strategies for women to combat stigma and promote life-sustaining behaviors.
Identifiants
pubmed: 30932700
doi: 10.1089/apc.2018.0282
pmc: PMC6459270
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
184-195Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI031834
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035004
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034989
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI134326
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034994
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000454
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103401
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH104114
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103408
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103397
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH095683
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103390
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034993
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD032632
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI042590
Pays : United States
Références
Cult Health Sex. 2018 May;20(5):489-503
pubmed: 28812457
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
AIDS Educ Prev. 2014 Dec;26(6):521-37
pubmed: 25490733
BMC Med Res Methodol. 2010 Feb 10;10:13
pubmed: 20144247
Am J Public Health. 2017 Jun;107(6):863-869
pubmed: 28426316
Sociol Health Illn. 2016 Jan;38(1):90-108
pubmed: 26382837
AIDS Patient Care STDS. 2014 Mar;28(3):136-43
pubmed: 24568654
AIDS Care. 2017 Nov;29(11):1337-1345
pubmed: 28599599
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640
pubmed: 24242258
AIDS Care. 2014;26(5):574-81
pubmed: 24116662
AIDS Patient Care STDS. 2009 Apr;23(4):267-76
pubmed: 19260770
J Int AIDS Soc. 2017 Feb 27;20(1):21462
pubmed: 28362064
J Urban Health. 2007 Nov;84(6):814-28
pubmed: 17786561
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):482-487
pubmed: 28885270
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):198-205
pubmed: 26885803
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Women Health. 2007;46(2-3):99-112
pubmed: 18160372
Medicine (Baltimore). 2016 Mar;95(13):e3171
pubmed: 27043679
AIDS Behav. 2013 Jun;17(5):1785-95
pubmed: 23456594
AIDS Patient Care STDS. 2007 Dec;21(12):956-69
pubmed: 18154492
AIDS Patient Care STDS. 2018 Oct;32(10):399-407
pubmed: 30277816
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7
pubmed: 21857529
AIDS Patient Care STDS. 2018 Oct;32(10):418-424
pubmed: 30277814
J Int AIDS Soc. 2009 Aug 06;12:15
pubmed: 19660113
PLoS One. 2018 Jan 2;13(1):e0189973
pubmed: 29293632
J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):257-263
pubmed: 29140873
J Community Health. 2015 Aug;40(4):642-51
pubmed: 25524210
AIDS Care. 2017 Nov;29(11):1364-1372
pubmed: 28325068
Addict Behav. 2018 Sep;84:110-117
pubmed: 29660593
AIDS Behav. 2013 Sep;17(7):2528-39
pubmed: 23474643
AIDS. 2014 Jun 19;28(10):1393-7
pubmed: 24556871
Int J Epidemiol. 2018 Apr 1;47(2):393-394i
pubmed: 29688497
AIDS Patient Care STDS. 2008 Nov;22(11):869-77
pubmed: 19025481
J Int AIDS Soc. 2013 Dec 23;16(1):18973
pubmed: 29874325
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):144-153
pubmed: 29135650
AIDS Patient Care STDS. 2016 Nov;30(11):519-527
pubmed: 27849373
Clin Infect Dis. 2007 Nov 15;45(10):1377-85
pubmed: 17968839
AIDS Behav. 2014 Jul;18(7):1237-46
pubmed: 24077930
AIDS Behav. 2017 Dec;21(12):3431-3439
pubmed: 29081045
Soc Sci Med. 2018 Jul;208:9-17
pubmed: 29753137
AIDS Patient Care STDS. 2018 Sep;32(9):368-378
pubmed: 30179530
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18734
pubmed: 24242268
J Acquir Immune Defic Syndr. 2018 May 1;78(1):9-15
pubmed: 29373394
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
Health Psychol. 2016 Oct;35(10):1126-1134
pubmed: 27089459
MMWR Morb Mortal Wkly Rep. 2016 Feb 05;65(4):83-5
pubmed: 26845101
J Behav Med. 2007 Oct;30(5):359-70
pubmed: 17588200
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e18-e22
pubmed: 27926668
Health Care Women Int. 2012;33(4):403-19
pubmed: 22420680
AIDS Care. 2018 Apr;30(4):409-416
pubmed: 29376409